Key technical specifications include dose accuracy (within 5%), cartridge and needle compatibility (e.g., ISO 11608-3 cartridges
Pre-restart assessment should include: Review of the reason for discontinuation and whether it has been adequately addressed Current weight and glycemic status (if diabetic) Assessment of gastrointestinal symptoms and any contraindications Medication reconciliation to identify potential drug interactions For patients taking insulin or sulfonylureas, consider dose reductions to prevent hypoglycemia For women of childbearing potential using oral contraceptives, recommend backup contraception for 4 weeks after restarting and after each dose increase Discussion of realistic expectations and commitment to continued treatment Patient counseling is essential
PlexusDx Precision Peptide Genetic Test (a $99 add-on after your first month of treatment) identifies your genetic predispositions across 14 metabolic pathways and 49 peptides, helping you and your healthcare provider select the most effective medication once breastfeeding is no longer a factor
Therapeutically, repleting hepatic GSH is rational
When you delay a shipment, the ship date is set to the day you choose (e.g., 1 month, 3 months, or a specific date)
